Pharmaceutical companies are increasingly relying on real-world data (RWD) to accelerate drug development and optimize clinical trial design. Despite this, accessing, analyzing, “Pharma teams often find themselves committing time and resources into exploratory conversations or technical scoping before they can even determine whether a dataset is